Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole (Q37274678)

19 August 2017

Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole (English)

1 reference

19 August 2017

0 references

staphylococcal pneumonia

1 reference

2

David P Nicolau

1 reference

19 August 2017

Keith A Rodvold

1

1 reference

19 August 2017

Thomas P Lodise

3

1 reference

19 August 2017

Mohammed Khashab

4

1 reference

19 August 2017

Gary J Noel

5

1 reference

19 August 2017

James B Kahn

6

1 reference

19 August 2017

Mark Gotfried

7

1 reference

19 August 2017

Sara A Murray

8

1 reference

19 August 2017

Susan Nicholson

9

1 reference

19 August 2017

Somvadee Laohavaleeson

10

1 reference

19 August 2017

Pamela R Tessier

11

1 reference

19 August 2017

G L Drusano

12

1 reference

19 August 2017

language of work or name

English

0 references

publication date

18 May 2009

1 reference

Antimicrobial Agents and Chemotherapy

19 August 2017

1 reference

19 August 2017

53

1 reference

19 August 2017

8

1 reference

19 August 2017

3294-3301

1 reference

In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

A sensitive assay of amoxicillin in mouse serum and broncho-alveolar lavage fluid by liquid-liquid extraction and reversed-phase HPLC.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Comparison of 99mTc-DTPA and urea for measuring cefepime concentrations in epithelial lining fluid

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715607

Ceftobiprole Medocaril: BAL5788, JNJ 30982081, JNJ30982081, RO 65-5788, RO 655788

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19451287

12 December 2020

inferred from PubMed ID database lookup

Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19451287

12 December 2020

inferred from PubMed ID database lookup

Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19451287

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.00144-09

1 reference

release_vxs7xl7e7bhkjnyrctbt4zcem4

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vxs7xl7e7bhkjnyrctbt4zcem4

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

19451287

1 reference